Capital World Investors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.1B | Buy |
1,419,000
+20,997
| +2% | +$16.1M | 0.15% | 135 |
|
|
2025
Q4 | $1.08B | Sell |
1,398,003
-600,363
| -30% | -$408M | 0.15% | 139 |
|
|
2025
Q3 | $1.12B | Buy |
1,998,366
+32,348
| +2% | +$18.3M | 0.15% | 137 |
|
|
2025
Q2 | $1.03B | Buy |
1,966,018
+27,384
| +1% | +$15.3M | 0.15% | 136 |
|
|
2025
Q1 | $1.23B | Sell |
1,938,634
-840,346
| -30% | -$578M | 0.2% | 112 |
|
|
2024
Q4 | $1.98B | Sell |
2,778,980
-1,519,407
| -35% | -$1.28B | 0.3% | 88 |
|
|
2024
Q3 | $4.52B | Sell |
4,298,387
-340,280
| -7% | -$379M | 0.7% | 30 |
|
|
2024
Q2 | $4.88B | Sell |
4,638,667
-16,188
| -0.3% | -$15.7M | 0.8% | 27 |
|
|
2024
Q1 | $4.48B | Sell |
4,654,855
-475,630
| -9% | -$452M | 0.74% | 30 |
|
|
2023
Q4 | $4.51B | Buy |
5,130,485
+23,146
| +0.5% | +$19.1M | 0.8% | 25 |
|
|
2023
Q3 | $4.2B | Sell |
5,107,339
-443,043
| -8% | -$348M | 0.83% | 26 |
|
|
2023
Q2 | $3.99B | Sell |
5,550,382
-280,204
| -5% | -$216M | 0.77% | 29 |
|
|
2023
Q1 | $4.79B | Sell |
5,830,586
-411,849
| -7% | -$311M | 0.99% | 20 |
|
|
2022
Q4 | $4.5B | Buy |
6,242,435
+16,836
| +0.3% | +$12.4M | 0.96% | 17 |
|
|
2022
Q3 | $4.29B | Sell |
6,225,599
-9,012
| -0.1% | -$5.67M | 0.96% | 17 |
|
|
2022
Q2 | $3.69B | Buy |
6,234,611
+284,777
| +5% | +$185M | 0.78% | 23 |
|
|
2022
Q1 | $4.16B | Buy |
5,949,834
+626,199
| +12% | +$396M | 0.72% | 28 |
|
|
2021
Q4 | $3.36B | Buy |
5,323,635
+3,635
| +0.1% | +$2.23M | 0.53% | 39 |
|
|
2021
Q3 | $3.22B | Buy |
5,320,000
+12,043
| +0.2% | +$7.48M | 0.55% | 40 |
|
|
2021
Q2 | $2.96B | Sell |
5,307,957
-876,163
| -14% | -$444M | 0.5% | 46 |
|
|
2021
Q1 | $2.93B | Sell |
6,184,120
-761,648
| -11% | -$371M | 0.54% | 39 |
|
|
2020
Q4 | $3.36B | Buy |
6,945,768
+301,398
| +5% | +$163M | 0.65% | 33 |
|
|
2020
Q3 | $3.72B | Sell |
6,644,370
-290,985
| -4% | -$176M | 0.81% | 25 |
|
|
2020
Q2 | $4.33B | Sell |
6,935,355
-197,925
| -3% | -$112M | 1.05% | 17 |
|
|
2020
Q1 | $3.48B | Sell |
7,133,280
-1,199,144
| -14% | -$495M | 1.01% | 18 |
|
|
2019
Q4 | $3.13B | Buy |
8,332,424
+125,777
| +2% | +$42.3M | 0.7% | 36 |
|
|
2019
Q3 | $2.28B | Buy |
8,206,647
+106,813
| +1% | +$31.6M | 0.55% | 50 |
|
|
2019
Q2 | $2.54B | Buy |
8,099,834
+608,166
| +8% | +$202M | 0.59% | 42 |
|
|
2019
Q1 | $3.08B | Buy |
7,491,668
+462,477
| +7% | +$190M | 0.75% | 38 |
|
|
2018
Q4 | $2.63B | Buy |
7,029,191
+644,868
| +10% | +$236M | 0.71% | 40 |
|
|
2018
Q3 | $2.58B | Buy |
6,384,323
+322,051
| +5% | +$123M | 0.63% | 42 |
|
|
2018
Q2 | $2.09B | Buy |
6,062,272
+1,363,384
| +29% | +$426M | 0.45% | 60 |
|
|
2018
Q1 | $1.62B | Sell |
4,698,888
-109,059
| -2% | -$37.9M | 0.36% | 77 |
|
|
2017
Q4 | $1.81B | Sell |
4,807,947
-1,759,869
| -27% | -$713M | 0.39% | 67 |
|
|
2017
Q3 | $2.94B | Sell |
6,567,816
-370,047
| -5% | -$176M | 0.67% | 42 |
|
|
2017
Q2 | $3.41B | Sell |
6,937,863
-147,658
| -2% | -$64.6M | 0.8% | 30 |
|
|
2017
Q1 | $2.75B | Sell |
7,085,521
-673,804
| -9% | -$250M | 0.66% | 42 |
|
|
2016
Q4 | $2.85B | Sell |
7,759,325
-51,213
| -0.7% | -$19.5M | 0.72% | 36 |
|
|
2016
Q3 | $3.14B | Buy |
7,810,538
+483,912
| +7% | +$194M | 0.82% | 32 |
|
|
2016
Q2 | $2.56B | Buy |
7,326,626
+312,008
| +4% | +$120M | 0.69% | 40 |
|
|
2016
Q1 | $2.53B | Buy |
7,014,618
+210,153
| +3% | +$86.6M | 0.7% | 38 |
|
|
2015
Q4 | $3.69B | Sell |
6,804,465
-168,116
| -2% | -$91.1M | 1.03% | 20 |
|
|
2015
Q3 | $3.24B | Sell |
6,972,581
-986,741
| -12% | -$530M | 0.95% | 23 |
|
|
2015
Q2 | $4.06B | Sell |
7,959,322
-104,854
| -1% | -$51.2M | 1.1% | 16 |
|
|
2015
Q1 | $3.64B | Buy |
8,064,176
+188,026
| +2% | +$79.7M | 0.98% | 24 |
|
|
2014
Q4 | $3.23B | Buy |
7,876,150
+490,450
| +7% | +$193M | 0.88% | 28 |
|
|
2014
Q3 | $2.66B | Buy |
7,385,700
+35,641
| +0.5% | +$11.9M | 0.75% | 36 |
|
|
2014
Q2 | $2.08B | Sell |
7,350,059
-282,962
| -4% | -$83.9M | 0.57% | 48 |
|
|
2014
Q1 | $2.29B | Sell |
7,633,021
-1,230,909
| -14% | -$379M | 0.65% | 38 |
|
|
2013
Q4 | $2.44B | Sell |
8,863,930
-204,999
| -2% | -$59M | 0.69% | 39 |
|
|
2013
Q3 | $2.84B | Buy |
9,068,929
+539,200
| +6% | +$142M | 0.86% | 28 |
|
|
2013
Q2 | $1.92B | Buy |
+8,529,729
| New | +$1.99B | 0.62% | 41 |
|
Other funds holding REGN
VCM
N
Capital World Investors's REGN Position: Q1 2026 in Review
Capital World Investors increased its Regeneron Pharmaceuticals (REGN) stake by 1.5% in Q1 2026, buying an estimated $16.1M and bringing the position to 1,419,000 shares worth $1.1B. The position accounts for 0.15% of the portfolio, ranked #135.
Capital World Investors first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.88B in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Capital World Investors held 1,419,000 shares of Regeneron Pharmaceuticals worth $1.1B as of Q1 2026.
- Capital World Investors bought 20,997 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $16.1M.
- Regeneron Pharmaceuticals made up 0.15% of Capital World Investors's portfolio in Q1 2026, its #135 holding.
- Capital World Investors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Capital World Investors's Regeneron Pharmaceuticals position peaked at $4.88B in Q2 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.